Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-23

Clinical Trial Update: Efficacy and Safety of Zenoctil in Reducing Body Weight [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the weight-loss efficacy and safety of Zenoctil in overweight individuals has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zenoctil

Snippet

Sponsor: InQpharm Group | Conditions: Overweight | Phase 3 | Status: COMPLETED | Results posted: 2015-04-23